Skip to main content

Ndfip1 restricts mTORC1 signalling and glycolysis in regulatory T cells to prevent autoinflammatory disease.

Citation
Layman, A. A. K., et al. “Ndfip1 Restricts Mtorc1 Signalling And Glycolysis In Regulatory T Cells To Prevent Autoinflammatory Disease.”. Nature Communications, p. 15677.
Center University of Pennsylvania
Author Awo Akosua Kesewa Layman, Guoping Deng, Claire E O'Leary, Samuel Tadros, Rajan M Thomas, Joseph M Dybas, Emily K Moser, Andrew D Wells, Nicolai M Doliba, Paula M Oliver
Abstract

Foxp3 T regulatory (T) cells suppress immune cell activation and establish normal immune homeostasis. How T cells maintain their identity is not completely understood. Here we show that Ndfip1, a coactivator of Nedd4-family E3 ubiquitin ligases, is required for T cell stability and function. Ndfip1 deletion in T cells results in autoinflammatory disease. Ndfip1-deficient T cells are highly proliferative and are more likely to lose Foxp3 expression to become IL-4-producing T2 effector cells. Proteomic analyses indicate altered metabolic signature of Ndfip1-deficient T cells and metabolic profiling reveals elevated glycolysis and increased mTORC1 signalling. Ndfip1 restricts T cell metabolism and IL-4 production via distinct mechanisms, as IL-4 deficiency does not prevent hyperproliferation or elevated mTORC1 signalling in Ndfip1-deficient T cells. Thus, Ndfip1 preserves T lineage stability and immune homeostasis by preventing the expansion of highly proliferative and metabolically active T cells and by preventing pathological secretion of IL-4 from T cells.

Year of Publication
2017
Journal
Nature communications
Volume
8
Number of Pages
15677
Date Published
12/2017
ISSN Number
2041-1723
DOI
10.1038/ncomms15677
Alternate Journal
Nat Commun
PMID
28580955
PMCID
PMC5465375
Download citation